© 2019 Next Science Limited - All Rights Reserved. Solution by MUFG Corporate Markets, a division of MUFG Pension & Market Services
Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.
Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]
MUFG Corporate Markets
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474
© 2019 Next Science Limited - All Rights Reserved. Solution by MUFG Corporate Markets, a division of MUFG Pension & Market Services